ATE407692T1 - Medizinische zusammensetzungen zur behandlung und vorbeugung von auf abnormaler blutgerinnung basierenden erkrankungen - Google Patents

Medizinische zusammensetzungen zur behandlung und vorbeugung von auf abnormaler blutgerinnung basierenden erkrankungen

Info

Publication number
ATE407692T1
ATE407692T1 AT00987688T AT00987688T ATE407692T1 AT E407692 T1 ATE407692 T1 AT E407692T1 AT 00987688 T AT00987688 T AT 00987688T AT 00987688 T AT00987688 T AT 00987688T AT E407692 T1 ATE407692 T1 AT E407692T1
Authority
AT
Austria
Prior art keywords
blood coagulation
prevention
treatment
pharmaceutical composition
blood clotting
Prior art date
Application number
AT00987688T
Other languages
English (en)
Inventor
Yasushi Nakatomi
Kazuhiko Tomokiyo
Tatsuya Araki
Kaori Teshima
Tomoko Watanabe
Tomohiro Nakagaki
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE407692T1 publication Critical patent/ATE407692T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00987688T 1999-12-24 2000-12-21 Medizinische zusammensetzungen zur behandlung und vorbeugung von auf abnormaler blutgerinnung basierenden erkrankungen ATE407692T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP36812299A JP4676585B2 (ja) 1999-12-24 1999-12-24 血液凝固異常に基づく疾患の治療・予防用医薬組成物

Publications (1)

Publication Number Publication Date
ATE407692T1 true ATE407692T1 (de) 2008-09-15

Family

ID=18491024

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00987688T ATE407692T1 (de) 1999-12-24 2000-12-21 Medizinische zusammensetzungen zur behandlung und vorbeugung von auf abnormaler blutgerinnung basierenden erkrankungen

Country Status (9)

Country Link
US (1) US6881721B2 (de)
EP (1) EP1240901B1 (de)
JP (1) JP4676585B2 (de)
CN (1) CN1222311C (de)
AT (1) ATE407692T1 (de)
DE (1) DE60040236D1 (de)
DK (1) DK1240901T3 (de)
ES (1) ES2312374T3 (de)
WO (1) WO2001047548A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4813017B2 (ja) 2001-07-10 2011-11-09 一般財団法人化学及血清療法研究所 薬剤学的に安定な止血用組成物
JP2007055899A (ja) * 2003-10-27 2007-03-08 Chemo Sero Therapeut Res Inst 血液凝固第ｘ因子を主剤とする血液凝固異常に基づく疾患の治療・予防用医薬組成物
WO2005107795A1 (en) * 2004-05-11 2005-11-17 Novo Nordisk Health Care Ag Use of factor viia for the treatment of burn traumas
WO2008023052A1 (en) * 2006-08-24 2008-02-28 Novo Nordisk Health Care Ag Combination of a fvii and a thrombin-activable factor x
WO2009028573A1 (ja) 2007-08-27 2009-03-05 National University Corporation Nagoya University 血液凝固障害におけるリバビリンの利用
DK2555704T3 (da) 2010-04-08 2019-08-05 Hemosonics Llc Visning af hæmostatiske parametre

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287180A (en) 1980-01-28 1981-09-01 Baxter Travenol Laboratories, Inc. Method for treating blood clotting factor inhibitors
US4663164A (en) 1980-01-28 1987-05-05 Baxter Travenol Laboratories, Inc. Aqueous compositions for treating blood clotting factor inhibitors
US4357321A (en) * 1980-01-28 1982-11-02 Baxter Travenol Laboratories, Inc. Method and composition for treating clotting factor inhibitors
US4286056A (en) 1980-01-28 1981-08-25 Baxter Travenol Laboratories, Inc. Method for making therapeutic enzyme compositions
EP0044343B1 (de) 1980-01-28 1984-08-22 Baxter Travenol Laboratories, Inc. Prothrombin enthaltende therapeutische zusammensetzungen und verfahren zur herstellung enzymatisch aktiver blutgerinnungsfaktoren aus prothrombin enthaltenden blutfraktionen
US4459288A (en) * 1981-05-11 1984-07-10 Baxter Travenol Laboratories, Inc. Therapeutic blood clotting factor compositions and their use
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
US4501731A (en) * 1983-06-27 1985-02-26 Tishkoff Garson H Treatment of disparate bleeding disorders with factor X zymogen
JP2824430B2 (ja) 1989-08-02 1998-11-11 財団法人化学及血清療法研究所 血液凝固第▲ｖｉｉ▼因子または活性型血液凝固第▲ｖｉｉ▼因子の調製方法
DE4325872C1 (de) * 1993-08-02 1994-08-04 Immuno Ag Virusinaktivierte Faktor Xa-Präparation
ATE200225T1 (de) * 1994-04-22 2001-04-15 Sanquin Bloedvoorziening Mittel für die behandlung von störungen des blutgerinnungsprozess
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
JP4046377B2 (ja) 1996-08-19 2008-02-13 財団法人化学及血清療法研究所 血液凝固第ｖｉｉ因子の活性化方法及び該方法に基づく活性化血液凝固第ｖｉｉ因子の製造方法
JPH1059866A (ja) 1996-08-19 1998-03-03 Chemo Sero Therapeut Res Inst 血液凝固第ｖｉｉ因子及び／もしくは活性化血液凝固第ｖｉｉ因子の製造方法

Also Published As

Publication number Publication date
ES2312374T3 (es) 2009-03-01
CN1434720A (zh) 2003-08-06
JP4676585B2 (ja) 2011-04-27
EP1240901B1 (de) 2008-09-10
WO2001047548A1 (fr) 2001-07-05
JP2001181204A (ja) 2001-07-03
EP1240901A1 (de) 2002-09-18
DE60040236D1 (de) 2008-10-23
EP1240901A4 (de) 2005-01-12
US6881721B2 (en) 2005-04-19
US20030060411A1 (en) 2003-03-27
CN1222311C (zh) 2005-10-12
DK1240901T3 (da) 2008-11-10

Similar Documents

Publication Publication Date Title
Ockerman et al. Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review
Moore et al. Fibrin sealant reduces the duration and amount of fluid1 drainage after axillary dissection: A randomized prospective clinical trial
EP0726749B1 (de) Hämostatisches pflaster
Frachon et al. Management options for dental extraction in hemophiliacs: a study of 55 extractions (2000–2002)
Longhurst Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence?
ATE292979T1 (de) Verwendung von aktiviertem protein-c zur behandlung überschiessender blutgerinnung bei sepsis
Liu et al. Tranexamic acid reduces occult blood loss, blood transfusion, and improves recovery of knee function after total knee arthroplasty: a comparative study
Tuthill et al. Assessment of topical hemostats in a renal hemorrhage model in heparinized rats
BR9910899A (pt) Compostos de ácido sulfÈnico ou sulfonilamino n-(hetero-aralquil)-azaeterocicliamida
Allam et al. In vivo effects of zoledronic acid on oral mucosal epithelial cells
O'Grady et al. An evaluation of fibrin tissue adhesive concentration and application thickness on skin graft survival
ATE407692T1 (de) Medizinische zusammensetzungen zur behandlung und vorbeugung von auf abnormaler blutgerinnung basierenden erkrankungen
Nilsson et al. Surgery of hemophiliacs—20 years' experience
Petratos et al. Transforming growth factor‐β2 (TGF‐β2) reverses the inhibitory effects of fibrin sealant on cutaneous wound repair in the pig
Kuffler Techniques for wound healing with a focus on pressure ulcers elimination
EP1240900A4 (de) Medizinische zusammensetzungen zur prävention und behandlung von thrombopathie assoziierenden hämorrhagischen erkrankungen
Wilde Evidence for the use of activated prothrombin complex concentrates (aPCCs) in the treatment of patients with haemophilia and inhibitors
Rothwell et al. ε-Amino caproic acid additive decreases fibrin bandage performance in a swine arterial bleeding model
DE59909356D1 (de) Pharmazeutische präparation, enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen
Lu et al. Hemocoagulase agkistrodon can prevent bleeding and induce hypofibrinogenemia in hepatic disease cases
Nair et al. “LIVER CLOT” after Periodontal Plastic Surgery
Montano-Pedroso et al. Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Antifibrinolytics
RU2057534C1 (ru) Способ лечения трофических язв
ATE337790T1 (de) Verwendung von cortisol-sequestriermitteln zur behandlung von hypercortisolaemie-verwandten erkrankungen
Mariona et al. Awareness on the management of bleeding disorders among dental students

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1240901

Country of ref document: EP